CC2D2B
gene geneOn this page
Also known as bA248J23.4bA690P14.3
Summary
CC2D2B (coiled-coil and C2 domain containing 2B, HGNC:31666) is a protein-coding gene on chromosome 10q24.1, encoding Protein CC2D2B (Q6DHV5).
Predicted to be involved in non-motile cilium assembly and protein localization to ciliary transition zone. Predicted to be active in ciliary transition zone.
Source: NCBI Gene 387707 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_001349008
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31666 |
| Approved symbol | CC2D2B |
| Name | coiled-coil and C2 domain containing 2B |
| Location | 10q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA248J23.4, bA690P14.3 |
| Ensembl gene | ENSG00000188649 |
| Ensembl biotype | protein_coding |
| Entrez | 387707 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 4 protein_coding, 3 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay, 1 retained_intron
ENST00000344386, ENST00000410012, ENST00000423344, ENST00000424464, ENST00000472454, ENST00000475252, ENST00000484685, ENST00000602648, ENST00000636965, ENST00000646931
RefSeq mRNA: 4 — MANE Select: NM_001349008
NM_001001732, NM_001130446, NM_001159747, NM_001349008
CCDS: CCDS58090, CCDS91310
Canonical transcript exons
ENST00000646931 — 35 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001197550 | 95927237 | 95927332 |
| ENSE00001454588 | 96019702 | 96019824 |
| ENSE00001454589 | 96019203 | 96019337 |
| ENSE00001454590 | 96016201 | 96016314 |
| ENSE00001454591 | 96013788 | 96013877 |
| ENSE00001454592 | 96012532 | 96012729 |
| ENSE00001578246 | 96024853 | 96024911 |
| ENSE00001664961 | 96012185 | 96012367 |
| ENSE00003543403 | 95922016 | 95922076 |
| ENSE00003548504 | 95924314 | 95924390 |
| ENSE00003559012 | 95981975 | 95982113 |
| ENSE00003572538 | 96009825 | 96009923 |
| ENSE00003609683 | 95924779 | 95924844 |
| ENSE00003636128 | 96027212 | 96027389 |
| ENSE00003642895 | 95983606 | 95983809 |
| ENSE00003777929 | 95992527 | 95992697 |
| ENSE00003791916 | 95937991 | 95938189 |
| ENSE00003793023 | 95961829 | 95961969 |
| ENSE00003793228 | 95938797 | 95938925 |
| ENSE00003794801 | 95955394 | 95955491 |
| ENSE00003795476 | 95965896 | 95965998 |
| ENSE00003796403 | 95949896 | 95950105 |
| ENSE00003797278 | 96004152 | 96004248 |
| ENSE00003797660 | 95966190 | 95966302 |
| ENSE00003798704 | 95991370 | 95991461 |
| ENSE00003800626 | 95938569 | 95938705 |
| ENSE00003815172 | 95995269 | 95995365 |
| ENSE00003816002 | 95988250 | 95988342 |
| ENSE00003817661 | 95972066 | 95972216 |
| ENSE00003822753 | 95996143 | 95996252 |
| ENSE00003827009 | 95968724 | 95968901 |
| ENSE00003827401 | 95974009 | 95974156 |
| ENSE00003842365 | 95911301 | 95911359 |
| ENSE00003899825 | 96031820 | 96033745 |
| ENSE00003900795 | 95907975 | 95908057 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 93.12.
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| kidney epithelium | UBERON:0004819 | 93.12 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 91.66 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 91.63 | gold quality |
| superficial temporal artery | UBERON:0001614 | 87.30 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.85 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.18 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 84.18 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 83.57 | gold quality |
| sperm | CL:0000019 | 81.43 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 80.98 | gold quality |
| upper arm skin | UBERON:0004263 | 80.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 80.02 | gold quality |
| myocardium | UBERON:0002349 | 79.30 | gold quality |
| cardia of stomach | UBERON:0001162 | 77.05 | gold quality |
| gingival epithelium | UBERON:0001949 | 75.36 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 74.44 | gold quality |
| tibial artery | UBERON:0007610 | 72.56 | gold quality |
| popliteal artery | UBERON:0002250 | 72.55 | gold quality |
| vastus lateralis | UBERON:0001379 | 72.33 | gold quality |
| quadriceps femoris | UBERON:0001377 | 71.89 | gold quality |
| corpus callosum | UBERON:0002336 | 71.46 | gold quality |
| saphenous vein | UBERON:0007318 | 71.43 | gold quality |
| colonic epithelium | UBERON:0000397 | 71.11 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 71.11 | gold quality |
| mammary duct | UBERON:0001765 | 70.92 | gold quality |
| gingiva | UBERON:0001828 | 70.84 | gold quality |
| mucosa of stomach | UBERON:0001199 | 70.82 | gold quality |
| secondary oocyte | CL:0000655 | 70.47 | gold quality |
| right coronary artery | UBERON:0001625 | 70.17 | gold quality |
| calcaneal tendon | UBERON:0003701 | 70.08 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 6.39 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The CC2D2B is a novel genetic modifier of the clinical phenotype in patients with hereditary angioedema due to C1 inhibitor deficiency. (PMID:38679185)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cc2d2b | ENSMUSG00000108929 |
| rattus_norvegicus | Cc2d2b | ENSRNOG00000070964 |
| drosophila_melanogaster | Cc2d2a | FBGN0263113 |
| caenorhabditis_elegans | mks-6 | WBGENE00010642 |
Paralogs (2): CC2D2A (ENSG00000048342), CEP76 (ENSG00000101624)
Protein
Protein identifiers
Protein CC2D2B — Q6DHV5 (reviewed: Q6DHV5)
All UniProt accessions (5): A0A1B0GUL2, A0A1W2PQR2, A0A5S8K7B6, Q6DHV5, R4GN90
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6DHV5-5 | 1 | yes |
| Q6DHV5-1 | 2 | |
| Q6DHV5-2 | 3 | |
| Q6DHV5-4 | 4 |
RefSeq proteins (2): NP_001123918, NP_001335937* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000008 | C2_dom | Domain |
| IPR028928 | CC2D2AN-C2 | Domain |
| IPR035892 | C2_domain_sf | Homologous_superfamily |
| IPR041510 | DUF5523 | Domain |
| IPR052434 | Tectonic-like_complex_comp | Family |
| IPR056288 | CEP76_C | Domain |
| IPR056290 | CEPT76/DRC7_peptidase-like_dom | Domain |
Pfam: PF15625, PF17661, PF24652, PF24656
UniProt features (11 total): splice variant 6, sequence variant 3, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6DHV5-F1 | 68.49 | 0.14 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 66 (showing top):
AAGCAAT_MIR137, GOBP_PROTEIN_LOCALIZATION_TO_CILIUM, GOBP_CILIUM_ORGANIZATION, GOBP_ORGANELLE_ASSEMBLY, ATGCTGG_MIR338, LYF1_01, TCCAGAT_MIR5165P, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_CELL_PROJECTION_ORGANIZATION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOCC_CILIARY_TRANSITION_ZONE, WGTTNNNNNAAA_UNKNOWN, GOCC_CILIUM, ATACTGT_MIR144, GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_TRANSITION_ZONE
GO Biological Process (2): protein localization to ciliary transition zone (GO:1904491), non-motile cilium assembly (GO:1905515)
GO Molecular Function (0):
GO Cellular Component (1): ciliary transition zone (GO:0035869)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein localization to cilium | 1 |
| cilium assembly | 1 |
| cilium | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
340 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CC2D2B | C3orf22 | Q8N5N4 | 591 |
| CC2D2B | RNASE12 | Q5GAN4 | 570 |
| CC2D2B | C12orf56 | Q8IXR9 | 544 |
| CC2D2B | SMIM17 | P0DL12 | 541 |
| CC2D2B | ANKRD62 | A6NC57 | 509 |
| CC2D2B | SH2D7 | A6NKC9 | 508 |
| CC2D2B | C22orf42 | Q6IC83 | 507 |
| CC2D2B | C1orf167 | Q5SNV9 | 507 |
| CC2D2B | SPDYE4 | A6NLX3 | 505 |
| CC2D2B | CLPSL1 | A2RUU4 | 479 |
| CC2D2B | EPCIP | Q9NYP8 | 479 |
| CC2D2B | RD3L | P0DJH9 | 478 |
| CC2D2B | SMIM21 | Q3B7S5 | 476 |
| CC2D2B | SPATA12 | Q7Z6I5 | 447 |
| CC2D2B | MGAT4D | A6NG13 | 447 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RALGDS | CC2D2B | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (6): CC2D2B (Proximity Label-MS), CC2D2B (Affinity Capture-MS), CC2D2B (Affinity Capture-MS), ACSBG1 (Cross-Linking-MS (XL-MS)), EIF5A2 (Cross-Linking-MS (XL-MS)), CHMP6 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A2RRS8, A4D1B5, A5PLK6, D3Z6S9, E7FA21, G3UYX5, O75747, O75901, O88480, O88869, Q2T9P0, Q3UMB5, Q3UPC7, Q3URV1, Q402B2, Q4R9E9, Q5SUS0, Q5T0N1, Q5XI56, Q5XX13, Q642P2, Q6DHV5, Q6INI0, Q6P2C0, Q7L0X2, Q80X60, Q86VV8, Q86WZ0, Q8CDN1, Q8IV33, Q8IXR9, Q8K342, Q8N7B9, Q8N7X0, Q8ND61, Q8NE09, Q8NG48, Q8R4Y8, Q8TDY2, Q8TEV9
Diamond homologs: Q6DHV5, Q8CFW7, Q95K30, Q9P2K1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3309 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:95911300:GAAA:G | acceptor_gain | 1.0000 |
| 10:95922084:A:AG | donor_gain | 1.0000 |
| 10:95922088:G:GG | donor_gain | 1.0000 |
| 10:95924386:CTAAG:C | donor_loss | 1.0000 |
| 10:95924387:TAAG:T | donor_loss | 1.0000 |
| 10:95924388:AAGGT:A | donor_loss | 1.0000 |
| 10:95924389:AG:A | donor_loss | 1.0000 |
| 10:95924390:GGTAA:G | donor_loss | 1.0000 |
| 10:95924391:GTAAT:G | donor_loss | 1.0000 |
| 10:95924392:T:A | donor_loss | 1.0000 |
| 10:95924774:TTCA:T | acceptor_loss | 1.0000 |
| 10:95924775:TCAG:T | acceptor_loss | 1.0000 |
| 10:95924776:CAG:C | acceptor_loss | 1.0000 |
| 10:95924777:A:AG | acceptor_gain | 1.0000 |
| 10:95924777:A:C | acceptor_loss | 1.0000 |
| 10:95924778:G:GA | acceptor_gain | 1.0000 |
| 10:95924778:GATT:G | acceptor_gain | 1.0000 |
| 10:95924778:GATTA:G | acceptor_gain | 1.0000 |
| 10:95924839:TCCA:T | donor_gain | 1.0000 |
| 10:95924840:CCAAG:C | donor_loss | 1.0000 |
| 10:95924842:AAGG:A | donor_loss | 1.0000 |
| 10:95924843:AGGT:A | donor_loss | 1.0000 |
| 10:95924845:G:A | donor_loss | 1.0000 |
| 10:95924846:T:A | donor_loss | 1.0000 |
| 10:95938565:AAAGT:A | acceptor_gain | 1.0000 |
| 10:96009821:ATAG:A | acceptor_gain | 1.0000 |
| 10:96019820:TACAG:T | donor_loss | 1.0000 |
| 10:96019821:ACAG:A | donor_loss | 1.0000 |
| 10:96019822:CAG:C | donor_loss | 1.0000 |
| 10:96019823:AG:A | donor_loss | 1.0000 |
AlphaMissense
9590 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:95949969:T:C | L292P | 0.996 |
| 10:95996224:T:A | W941R | 0.996 |
| 10:95996224:T:C | W941R | 0.996 |
| 10:95974089:T:A | W626R | 0.995 |
| 10:95974089:T:C | W626R | 0.995 |
| 10:95938686:G:C | R218P | 0.994 |
| 10:95949990:T:C | F299S | 0.994 |
| 10:96027226:T:C | L1321P | 0.994 |
| 10:95972169:T:C | F583S | 0.992 |
| 10:96019771:T:A | W1279R | 0.992 |
| 10:96019771:T:C | W1279R | 0.992 |
| 10:95950038:T:C | L315P | 0.991 |
| 10:96027250:G:C | R1329P | 0.991 |
| 10:96031931:G:C | A1413P | 0.991 |
| 10:95972168:T:C | F583L | 0.990 |
| 10:95972170:T:A | F583L | 0.990 |
| 10:95972170:T:G | F583L | 0.990 |
| 10:95983718:T:C | L732P | 0.990 |
| 10:95996226:G:C | W941C | 0.989 |
| 10:95996226:G:T | W941C | 0.989 |
| 10:95974072:T:C | L620P | 0.988 |
| 10:95983708:C:A | R729S | 0.988 |
| 10:95968798:T:A | V514D | 0.987 |
| 10:95992660:G:C | A869P | 0.987 |
| 10:95996168:T:A | V922D | 0.987 |
| 10:95968739:A:C | R494S | 0.986 |
| 10:95968739:A:T | R494S | 0.986 |
| 10:95968777:T:A | I507K | 0.986 |
| 10:95972213:A:C | S598R | 0.986 |
| 10:95972215:C:A | S598R | 0.986 |
dbSNP variants (sampled 300 via entrez): RS1000011125 (10:95932227 G>T), RS1000035530 (10:95914694 C>G), RS1000055699 (10:95974955 T>A), RS1000055967 (10:96026641 C>T), RS1000066435 (10:95922954 A>T), RS1000142164 (10:95956616 C>T), RS1000207715 (10:95982760 G>A), RS1000223528 (10:95929360 G>A), RS1000254780 (10:95926316 T>C), RS1000257252 (10:96020980 A>G,T), RS1000279959 (10:95982403 T>C), RS1000314031 (10:95915448 A>G), RS1000374172 (10:96018786 T>G), RS1000393930 (10:95984146 C>T), RS1000467743 (10:95911146 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006479_24 | Diverticular disease | 9.000000e-06 |
| GCST009174_2 | Response to (pegylated) interferon in chronic hepatitis B | 1.000000e-06 |
| GCST010726_42 | Periventricular white matter hyperintensities | 5.000000e-07 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009959 | diverticular disease |
| EFO:0007859 | response to interferon |
| EFO:0005665 | white matter hyperintensity measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| 4-aminophenylarsenoxide | affects binding, decreases reaction | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Arsenic Trioxide | affects binding, decreases reaction | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Mercuric Chloride | decreases expression | 1 |
| Dronabinol | increases expression | 1 |
| Thimerosal | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.